177 related articles for article (PubMed ID: 30214377)
1. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.
Weagel EG; Burrup W; Kovtun R; Velazquez EJ; Felsted AM; Townsend MH; Ence ZE; Suh E; Piccolo SR; Weber KS; Robison RA; O'Neill KL
Cancer Cell Int; 2018; 18():135. PubMed ID: 30214377
[TBL] [Abstract][Full Text] [Related]
2. Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells.
Velazquez EJ; Brindley TD; Shrestha G; Bitter EE; Cress JD; Townsend MH; Berges BK; Robison RA; Weber KS; O'Neill KL
Cancer Cell Int; 2020; 20():127. PubMed ID: 32317865
[TBL] [Abstract][Full Text] [Related]
3. Thymidine kinase 1 through the ages: a comprehensive review.
Bitter EE; Townsend MH; Erickson R; Allen C; O'Neill KL
Cell Biosci; 2020 Nov; 10(1):138. PubMed ID: 33292474
[TBL] [Abstract][Full Text] [Related]
4. Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane.
Townsend MH; Anderson MD; Weagel EG; Velazquez EJ; Weber KS; Robison RA; O'Neill KL
Onco Targets Ther; 2017; 10():1921-1932. PubMed ID: 28408844
[TBL] [Abstract][Full Text] [Related]
5. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
6. Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.
Weagel EG; Meng W; Townsend MH; Velazquez EJ; Brog RA; Boyer MW; Weber KS; Robison RA; O'Neill KL
Onco Targets Ther; 2017; 10():4355-4367. PubMed ID: 28919785
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
8. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
[TBL] [Abstract][Full Text] [Related]
9. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
10. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
11. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
[TBL] [Abstract][Full Text] [Related]
12. Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.
Bolayirli M; Papila C; Korkmaz GG; Papila B; Aydoğan F; Karataş A; Uzun H
J Clin Lab Anal; 2013 May; 27(3):220-6. PubMed ID: 23686779
[TBL] [Abstract][Full Text] [Related]
13. Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming.
Zuo S; Wang H; Li L; Pan H; Lu L
Front Oncol; 2022; 12():802807. PubMed ID: 35311151
[TBL] [Abstract][Full Text] [Related]
14. Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy.
Velazquez EJ; Cress JD; Humpherys TB; Mortimer TO; Bellini DM; Skidmore JR; Smith KR; Robison RA; Weber SK; O'Neill KL
PLoS One; 2022; 17(3):e0264822. PubMed ID: 35239730
[TBL] [Abstract][Full Text] [Related]
15. Thymidine kinase 1 as a target is regulated by the hsa-let-7b-5p/LINC00665 axis and affects NSCLC prognosis.
Zhu XD; Fan YF; Zhao Y; Song XY; Liu XS; Gao ZJ; Yuan K
Heliyon; 2023 Nov; 9(11):e21328. PubMed ID: 37954276
[TBL] [Abstract][Full Text] [Related]
16. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.
von Euler H; Eriksson S
Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma.
He E; Xu XH; Guan H; Chen Y; Chen ZH; Pan ZL; Tang LL; Hu GZ; Li Y; Zhang M; Zhou J; Eriksson S; Fornander T; Skog S
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):352-8. PubMed ID: 20544519
[TBL] [Abstract][Full Text] [Related]
19. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.
Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S
BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716
[TBL] [Abstract][Full Text] [Related]
20. Rice callus suspension culture inhibits growth of cell lines of multiple cancer types and induces apoptosis in lung cancer cell line.
Rahman N; Dhadi SR; Deshpande A; Ramakrishna W
BMC Complement Altern Med; 2016 Nov; 16(1):427. PubMed ID: 27806706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
